These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27714060)

  • 21. Role of kisspeptin in polycystic ovarian syndrome: A metabolomics study.
    Zhao T; Xiao X; Li L; Tao X; He W; Zhang Q; Wu X; Yuan T
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):315-325. PubMed ID: 36843187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study.
    Troisi J; Cinque C; Giugliano L; Symes S; Richards S; Adair D; Cavallo P; Sarno L; Scala G; Caiazza M; Guida M
    J Ovarian Res; 2019 Mar; 12(1):25. PubMed ID: 30904021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic Insight into Polycystic Ovary Syndrome-An Overview.
    Rajska A; Buszewska-Forajta M; Rachoń D; Markuszewski MJ
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
    Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
    BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum metabolomics study of Traditional Chinese medicine formula intervention to polycystic ovary syndrome.
    Lu C; Zhao X; Li Y; Li Y; Yuan C; Xu F; Meng X; Hou L; Xu G
    J Pharm Biomed Anal; 2016 Feb; 120():127-33. PubMed ID: 26730509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Histidine Supplementation on Global Serum and Urine
    Du S; Sun S; Liu L; Zhang Q; Guo F; Li C; Feng R; Sun C
    J Proteome Res; 2017 Jun; 16(6):2221-2230. PubMed ID: 28447460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites.
    Dhayat NA; Marti N; Kollmann Z; Troendle A; Bally L; Escher G; Grössl M; Ackermann D; Ponte B; Pruijm M; Müller M; Vogt B; Birkhäuser MH; Bochud M; Flück CE;
    PLoS One; 2018; 13(10):e0203903. PubMed ID: 30308019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS).
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Apr; 14(1):21. PubMed ID: 37076926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome.
    Yang Z; Cai X; Xu X; Xu Z; Ye S; Wang Y; Hong Y; Shen B; Liao Q; Xie Z; Wang X
    Anal Biochem; 2022 Jun; 647():114665. PubMed ID: 35339450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
    Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
    Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment.
    Omabe M; Elom S; Omabe KN
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):221-229. PubMed ID: 29359679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Analysis of the Biochemical Changes in Rats with Polycystic Ovary Syndrome (PCOS) Using Urinary 1H NMR-Based Metabonomics.
    Huang W; Li S; Luo N; Lu K; Ban S; Lin H
    Horm Metab Res; 2020 Jan; 52(1):49-57. PubMed ID: 31945791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the levels of plasma amino acids in polycystic ovary syndrome--A pilot study.
    Unni SN; Lakshman LR; Vaidyanathan K; Subhakumari KN; Menon NL
    Indian J Med Res; 2015 Nov; 142(5):549-54. PubMed ID: 26658589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome.
    Sóter MO; Ferreira CN; Sales MF; Candido AL; Reis FM; Milagres KS; Ronda C; Silva IO; Sousa MO; Gomes KB
    Cytokine; 2015 Dec; 76(2):227-235. PubMed ID: 26141422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
    Jiang L; Huang J; Chen Y; Yang Y; Li R; Li Y; Chen X; Yang D
    Endocrine; 2016 Jul; 53(1):280-90. PubMed ID: 26860517
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.